Ephraim Resources Limited Stock price

Equities

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 11:47:55 2017-02-27 pm EST 5-day change 1st Jan Change
0.002 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -.--%
Sales 2017 16.01K 10.45K Sales 2018 124 80.94 Capitalization 3.08M 2.01M
Net income 2017 - 0 Net income 2018 - 0 EV / Sales 2017 223 x
Net Debt 2017 497K 324K Net Debt 2018 548K 358K EV / Sales 2018 29,261 x
P/E ratio 2017
-6.41 x
P/E ratio 2018
-3.16 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 68.23%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
President - -
Chief Operating Officer - -
Director/Board Member 58 20-01-16
Members of the board TitleAgeSince
Director/Board Member 58 20-01-16
Director/Board Member - 20-01-16
Director/Board Member - -
More insiders
Ephraim Resources Limited is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia. It has developed a methodology to develop nipah palm fit for cropping on an industrial scale and optimize the use of degraded land for nipah palm plantations in Indonesia, and to produce sugar. The Company, through its subsidiary, PT First Flower (PTFF), has completed plantation trials and has rights over 11,800 hectares of land for nipah palm cultivation. PTFF has land use rights in the Meranti District, Riau province for over 8,000 hectares for non-wood products; in the Tanah Laut District, South Kalimantan province for over 1,200 hectares, and in the Kota Baru District, South Kalimantan province for over 2,600 hectares.
More about the company
  1. Stock
  2. Equities
  3. Stock Ephraim Resources Limited - Australian S.E.